Inputs: momentum, trendVelocity
Mixed signal: momentum 44/100, trend 65/100.
Prediction result · Ensemble engineUpdated 6:20 AM
NVONovo Nordisk A/S stock price outlook
$40.00+2.2% since prev closeNeutral
Novo Nordisk A/S (NVO) is trading at $40, up 2.2% since the previous close and +2.43% over the past week. Price sits below its 50-day average by 2.99%, with price momentum at 44/100 and trend velocity at 65/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is moderate (45/100) and the stock is 17% of the way up its 52-week range. The weighted factor score lands at 56/100 — a neutral signal. Research only, not investment advice.
Universal leanmarket
NVO
Novo Nordisk A/S
$40.00+2.20%
LEANNEUTRAL / wait for cleaner tape
WHY
- Novo Nordisk A/S (NVO) is trading at $40, up 2.2% since the previous close and +2.43% over the past week. Price sits below its 50-day average by 2.99%, with price momentum at 44/100 and trend velocity at 65/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is moderate (45/100) and the stock is 17% of the way up its 52-week range. The weighted factor score lands at 56/100 — a neutral signal. Research only, not investment advice.
- Bull input: Price near 52-week lows (17% of range) with trend turning up — mean-reversion candidate.
- Bear input: No bearish case in the sources.
RISK
Signals are model output from public data, not personalized investment advice.
INVALIDATE
Invalidate when a clear catalyst or directional print replaces the mixed tape.
AI Signal
Neutral · Lean
live data
Full public-market mode: chart history, quote, and news inputs were available.
Chart feed
Cron market chart feed
Quote/history
Six-month public chart history loaded.
News feed
No relevant current headlines found.
Signal inputs
Technical factors and news sentiment evaluated across multiple signal inputs.
News Sentiment50/100
Price Momentum44/100
Trend Velocity65/100
Volatility Risk45/100
Historical Modeling: Visualized ranges are mathematically derived from historic volatility metrics, corporate filings, and option-implied volume profiles. They represent statistical points of interest for research purposes, not financial execution commands or advice.
Why It Matters
Signal Explanation
Novo Nordisk A/S (NVO) is trading at $40, up 2.2% since the previous close and +2.43% over the past week. Price sits below its 50-day average by 2.99%, with price momentum at 44/100 and trend velocity at 65/100. Sentiment across 0 recent headlines reads mixed at 50/100. Volatility risk is moderate (45/100) and the stock is 17% of the way up its 52-week range. The weighted factor score lands at 56/100 — a neutral signal. Research only, not investment advice.
Analyst Engine · Specialist model ensemble
Trees disagree — no clear lean on NVO
Weighted factor score across 16 signal inputs evaluating 9 features: momentum, news, volume, volatility, range, sentiment divergence, trend structure, and oscillator. Consensus and weighting applied. Each specialist bot inspects a different slice of the feature set, casts a directional vote, and contributes a confidence weight to the final score.
Engine edgeLeanNeutral
Inputs: newsSentiment, dayChange
Sentiment 50/100 + price 2.2% are both mid-range.
Inputs: unusualVolume, dayChange
Volume read 58/100 with price drift 2.2% — no clear footprint.
Inputs: volatilityRisk, momentum
Vol regime 45/100 is mid-range — no edge.
Inputs: pctOfRange, trendVelocity
Price near 52-week lows (17% of range) with trend turning up — mean-reversion candidate.
Inputs: newsSentiment, weekChange
Sentiment 50/100 vs week change 2.4% are in agreement — no divergence edge.
Inputs: vsSma50, momentum
Price within 3.0% of the 50d SMA — no clear structural read.
Inputs: momentum, trendVelocity
Oscillator at 55 — neutral zone.
Inputs: momentum, dayChange, vsSma50
Momentum 44/100 is not strong enough to confirm a breakout.
Inputs: newsSentiment, weekChange
News 50/100 and weekly change 2.4% do not create a clean follow-through read.
Inputs: unusualVolume, trendVelocity
Volume 58/100 does not show a dry-up signal.
Inputs: volatilityRisk, pctOfRange, momentum
Volatility 45/100 does not give a clean compression read.
Inputs: pctOfRange, dayChange, weekChange
Range position 17% is too middle-of-the-road to matter.
Inputs: newsSentiment, momentum, weekChange
Sentiment 50/100 and momentum 44/100 are not aligned enough for a clean read.
Inputs: vsSma50, momentum, trendVelocity
50d SMA distance -3.0% is not decisive.
Inputs: momentum, trendVelocity, weekChange
Oscillator at 55 does not show a rebound edge.
Why the ensemble agrees
- Mixed signal: momentum 44/100, trend 65/100.
- Sentiment 50/100 + price 2.2% are both mid-range.
- Price within 3.0% of the 50d SMA — no clear structural read.
Counter-trees
- Price near 52-week lows (17% of range) with trend turning up — mean-reversion candidate.
Bull Case
- Price near 52-week lows (17% of range) with trend turning up — mean-reversion candidate.
Bear Case
- No bearish case in the sources.
Latest Market Headlines
Headline titles only, from the publisher named on each card. Each links to the original story.
No current headlines passed the relevance filter. The watch panel above still shows the catalysts and risk factors being tracked.
Key stats
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Market cap
- $177.12B
- 52-week range
- $64.16/$35.12
- Volume
- 15,277,524
- Avg volume
- 1,065,214
- Analyst 1-yr target
- $42.20
- Exchange
- NYSE
Source: Nasdaq public quote data. Research only.
Earnings Intelligence
Next
Nov 4, 2026
Estimate
$0.81
Actual
$0.96
- • Last report Aug 4, 2026 (Jun 2026): EPS $0.96 vs $0.82 expected, +17.07% surprise.
- • Beat estimates in 4 of the last 4 quarters.
- • Next report expected Nov 4, 2026, consensus EPS $0.81 (Zacks estimate via Nasdaq; the company may confirm a different date).
Risk Warnings
- • Signals are model output from public data, not personalized investment advice.
- • Markets can move against any signal regardless of the score.
- • Confirm liquidity, spreads, and your own thesis before acting.
NVO questions
What is the MarketPicks AI signal for Novo Nordisk A/S stock (NVO)?
As of Nov 2, 1:20 AM ET, the ensemble reads neutral on NVO — no consensus — 15 of 16 bots holding, with 1 bull, 0 bear and 15 hold votes from 16 specialist bots. Research only, not investment advice.
What is the latest NVO price on MarketPicks?
NVO was $40.00 on the latest quote (Nov 2, 1:20 AM ET), +2.2% since the previous close. Quotes can be delayed.
What do the momentum and trend scores for NVO mean?
Scores run from 0 to 100, with 50 neutral. NVO shows momentum 44/100, trend velocity 65/100 and volatility risk 45/100, with news sentiment at 50/100.
Not financial advice. MarketPicks.ai is an impersonal research tool. AI output can be wrong. Investing involves risk of loss. Do your own research and consult a licensed professional. Full disclaimer.